CSTL Annual Working Capital
$247.97 M
-$8.19 M-3.20%
31 December 2023
Summary:
As of January 22, 2025, CSTL annual working capital is $247.97 million, with the most recent change of -$8.19 million (-3.20%) on December 31, 2023. During the last 3 years, it has fallen by -$160.75 million (-39.33%). CSTL annual working capital is now -39.33% below its all-time high of $408.72 million, reached on December 31, 2020.CSTL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Quarterly Working Capital
$300.48 M
+$19.53 M+6.95%
30 September 2024
Summary:
As of January 22, 2025, CSTL quarterly working capital is $300.48 million, with the most recent change of +$19.53 million (+6.95%) on September 30, 2024. Over the past year, it has increased by +$52.51 million (+21.18%). CSTL quarterly working capital is now -26.55% below its all-time high of $409.09 million, reached on March 31, 2021.CSTL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.2% | +21.2% |
| 3 y3 years | -39.3% | +21.2% |
| 5 y5 years | +2077.3% | +21.2% |
CSTL Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.6% | at low | -8.6% | +27.7% |
| 5 y | 5-year | -39.3% | +144.6% | -26.6% | +196.6% |
| alltime | all time | -39.3% | >+9999.0% | -26.6% | +2538.3% |
Castle Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $300.48 M(+6.9%) |
| June 2024 | - | $280.95 M(+6.5%) |
| Mar 2024 | - | $263.82 M(+6.4%) |
| Dec 2023 | $247.97 M(-3.2%) | $247.97 M(+1.9%) |
| Sept 2023 | - | $243.30 M(+3.4%) |
| June 2023 | - | $235.34 M(-2.3%) |
| Mar 2023 | - | $240.96 M(-5.9%) |
| Dec 2022 | $256.16 M(-22.1%) | $256.16 M(-4.2%) |
| Sept 2022 | - | $267.47 M(-3.6%) |
| June 2022 | - | $277.39 M(-6.6%) |
| Mar 2022 | - | $296.92 M(-9.7%) |
| Dec 2021 | $328.86 M | $328.86 M(-10.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $368.59 M(-1.2%) |
| June 2021 | - | $373.05 M(-8.8%) |
| Mar 2021 | - | $409.09 M(+0.1%) |
| Dec 2020 | $408.72 M(+303.1%) | $408.72 M(+139.3%) |
| Sept 2020 | - | $170.82 M(+2.0%) |
| June 2020 | - | $167.43 M(+65.3%) |
| Mar 2020 | - | $101.30 M(-0.1%) |
| Dec 2019 | $101.39 M(+790.3%) | $101.39 M(+0.8%) |
| Sept 2019 | - | $100.63 M(+499.7%) |
| June 2019 | - | $16.78 M(-22.8%) |
| Mar 2019 | - | $21.74 M(+90.8%) |
| Dec 2018 | $11.39 M(+678.1%) | $11.39 M |
| Dec 2017 | $1.46 M | - |
FAQ
- What is Castle Biosciences annual working capital?
- What is the all time high annual working capital for Castle Biosciences?
- What is Castle Biosciences annual working capital year-on-year change?
- What is Castle Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Castle Biosciences?
- What is Castle Biosciences quarterly working capital year-on-year change?
What is Castle Biosciences annual working capital?
The current annual working capital of CSTL is $247.97 M
What is the all time high annual working capital for Castle Biosciences?
Castle Biosciences all-time high annual working capital is $408.72 M
What is Castle Biosciences annual working capital year-on-year change?
Over the past year, CSTL annual working capital has changed by -$8.19 M (-3.20%)
What is Castle Biosciences quarterly working capital?
The current quarterly working capital of CSTL is $300.48 M
What is the all time high quarterly working capital for Castle Biosciences?
Castle Biosciences all-time high quarterly working capital is $409.09 M
What is Castle Biosciences quarterly working capital year-on-year change?
Over the past year, CSTL quarterly working capital has changed by +$52.51 M (+21.18%)